RNS Number : 1186D
Willis Towers Watson PLC
23 October 2020
APPENDIX 3 DISCLOSURE FORMS
FORM 8.1(a)&(b)(i)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT WITH THEM FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS
1.
KEY
INFORMATION
|
Nameofpersondealing
(Note
1)
|
John Haley
|
|
Companydealtin
|
Willis Towers Watson plc
|
|
Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate(Note2)
|
Ordinary Shares of $0.000304635 each
|
|
Date
of
dealing
|
15 October 2020
|
2.
INTERESTS AND SHORT POSITIONS
(a)
Interests
and
short
positions
(following
dealing)
in
the
class
of
relevant
security
dealt
in
(Note
3)
|
|
Long
|
Short
|
|
|
Number
|
|
(%)
|
Number
|
|
(%)
|
|
(1)Relevantsecurities
|
Ordinary Shares: 124,927 (0.097%)
|
|
|
(2)
Derivatives
(other
than
options)
|
N/A
|
|
|
(3)Optionsandagreementstopurchase/sell
|
Restricted share units ("RSUs") pursuant to Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees: 109,506 (0.085%)
RSU's under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees: 13,263 (0.010%)
Dividend equivalent rights accrued on ordinary shares earned under performance based RSU award: 6,613 (0.005%)
|
|
|
Total
|
254,309 (0.197%)
|
|
| |
|
|
|
|
|
|
(b)
Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
|
Classofrelevantsecurity:
|
Long
|
Short
|
|
|
|
Number
|
|
(%)
|
Number
|
|
(%)
|
|
(1)Relevantsecurities
|
N/A
|
|
|
|
(2)
Derivatives
(other
than
options)
|
N/A
|
|
|
|
(3)Optionsandagreementstopurchase/sell
|
Options: 150,235 (0.117%)
Vested WTW Shares that will settle upon termination of service: 274,134 (0.213%)
2020 long-term incentive performance based RSU award (unearned): 47,374 (0.037%)
2019 long term- incentive performance based RSU award (unearned): 53,996 (0.042%)
|
|
|
|
Total
|
525,739 (0.408%)
|
|
|
| |
|
|
|
|
|
|
|
Ap10
3.
DEALINGS
(Note
4)
(a) Purchases and sales
|
Purchase/sale
|
Numberofrelevantsecurities
|
Priceperunit
(Note
5)
|
|
|
|
|
|
|
|
|
(b) Derivatives transactions (other than options transactions)
|
Productname,
e.g.
CFD
|
Natureoftransaction
(Note
6)
|
Numberofrelevantsecurities
(Note
7)
|
Priceperunit
(Note
5)
|
|
|
|
|
|
|
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
|
Product
name,
e.g.
call
option
|
Writing,
selling,
purchasing,
varyingetc.
|
Number
of
securities
to
which
the
option
relates
(Note
7)
|
Exercise
price
|
Type,
e.g.
American,
Europeanetc.
|
Expiry
date
|
Option
money
paid/received
perunit
(Note
5)
|
|
RSUs pursuant to Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees
|
Accrual pursuant to dividend allocations
|
342
|
N/A
|
N/A
|
N/A
|
$0
|
|
RSUs under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees
|
Accrual pursuant to dividend allocations
|
41
|
N/A
|
N/A
|
N/A
|
$0
|
|
Dividend equivalent rights accrued on ordinary shares earned under performance- based RSU award
|
Accrual of dividend equivalent rights
|
878
|
N/A
|
N/A
|
N/A
|
$0
|
(ii) Exercising
|
Productname,
e.g.
call
option
|
Numberofsecurities
|
Exercisepriceper unit
(Note
5)
|
|
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
|
Nature
of
transaction
(Note
8)
|
Details
|
Price
per
unit
(if applicable)
(Note 5)
|
|
|
|
|
Ap11
4.
OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any
relevant securities to which any derivative referred to on this form is referenced. If none, this
should be stated.
N/A
Is a Supplemental Form 8 attached?
(Note
9)
NO
|
Dateofdisclosure
|
22 October 2020
|
|
Contact
name
|
Cindy Hanna
|
|
Telephone
number
|
+1 (212) 915-7994
|
|
Name
of
offeree/offeror
with
which
acting
in
concert
|
Willis Towers Watson plc
|
|
Specifycategoryandnatureof actinginconcertstatus
|
Director
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END
ISEPPGGAUUPUGQW
|
